Cancer Research

Galectin-9 Emerges as New Target for Chronic Lymphocytic Leukemia Immunotherapy

Multi-omics study reveals exhausted T-cells in CLL lymph nodes and identifies galectin-9 as a promising therapeutic target for overcoming immune evasion.